Steward Partners Investment Advisory, LLC Innate Pharma Sa Transaction History
Steward Partners Investment Advisory, LLC
- $9.37 Billion
- Q2 2024
A detailed history of Steward Partners Investment Advisory, LLC transactions in Innate Pharma Sa stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 200 shares of IPHA stock, worth $450. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200
Previous 200
-0.0%
Holding current value
$450
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding IPHA
# of Institutions
9Shares Held
242KCall Options Held
0Put Options Held
0-
Optiver Holding B.V. Amsterdam, P787.4KShares$196,5420.0% of portfolio
-
Exchange Traded Concepts, LLC86.2KShares$194,0330.0% of portfolio
-
Morgan Stanley New York, NY43.5KShares$97,9290.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il23.5KShares$52,9350.0% of portfolio
-
Barclays PLC London, X0412Shares$9270.0% of portfolio
About Innate Pharma SA
- Ticker IPHA
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 79,893,000
- Market Cap $180M
- Description
- Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and periphera...